BSE filing, NSE: NCL. Summary written from the filing by ALFA Finder's alert engine.
NCL Research and Financial Services Ltd: key numbers
- Share price
- ₹0.60
- Market cap
- ₹94.19 Cr
- Revenue (annual)
- ₹6.16 Cr
- Net profit (annual)
- ₹-2.60 Cr
- P/E (TTM)
- -30.7×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NCL Research and Financial Services Ltd
All →NCL Research and Financial Services Other Announcement
NCL Research & Financial Services declared non-applicability of SEBI Regulation 57(5) for the quarter ended September 30, 2026, as it has no non-convertible securities.
NCL Research and Financial Services Annual General Meeting
NCL Research & Financial Services Limited conducted its 41st Annual General Meeting on September 29, 2026. Shareholders considered the adoption of financial statements and the reappointment of directors.
NCL Research and Financial Services Other Announcement
NCL Research & Financial Services Ltd submitted a non-applicability declaration for Regulation 57(4). The company confirmed it has no outstanding non-convertible securities or associated payment obligations.
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors Ltd (non-promoter) acquired 8.70 crore shares of NCL Research & Financial Services Ltd via a rights issue allotment.
NCL Research and Financial Services Annual General Meeting
NCL Research & Financial Services Limited announced the closure of its register of members from 23rd September 2026 to 29th September 2026 for its Annual General Meeting.
NCL Research and Financial Services Capital Structure Change
NCL Research & Financial Services announced a rights issue of Rs. 49.95 Crore. The issue opens on September 3, 2026, with an entitlement ratio of 7:15.
- Value
- ₹49.95 Cr
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.